Ringing a Bell on the Final Day of Radiation Therapy in Improving the Memory of Distress in Cance⦠(NCT02970617) | Clinical Trial Compass
CompletedNot Applicable
Ringing a Bell on the Final Day of Radiation Therapy in Improving the Memory of Distress in Cancer Patients
United States82 participantsStarted 2016-08-15
Plain-language summary
This clinical trial studies how well ringing a bell on the final day of radiation therapy works in improving the memory of distress in cancer patients. Ringing a bell on the final day of radiation therapy may improve the memory of how painful the treatment was.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosis of cancer
* Definitive radiation treatment with or without concurrent chemotherapy with curative intent; treatment prior to radiation therapy is acceptable (e.g. surgery, chemotherapy)
* Ability to understand and the willingness to sign a written informed consent; consents will be provided in English or Spanish
* Able to speak English or Spanish (questionnaires will be in English and Spanish)
Exclusion Criteria:
* Patients with either a malignant central nervous system (CNS)-primary cancer or with brain metastases; patients do not need to undergo brain imaging unless indicated per standard workup and management (e.g. advanced stage lung cancer receiving definitive therapy)
* Patients who will be receiving surgery or adjuvant chemotherapy within 1 month following radiation treatment
* Patients with widespread metastatic disease (\> 3 distant metastases); patients with oligometastatic disease (=\< 3 distant metastases) are allowed only if they are receiving definitive (curative) radiation therapy (RT) with or without chemotherapy
What they're measuring
1
Distress memory scales as assessed by the 11-point Numeric Rating Scale